Tokyo Tape
Sign in
← Astena Holdings

Quarterly report · Q3

8095.TEDINET S100PC1Z
Period2021-12-01 → 2022-08-31
Filed2022-10-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥36.9bn2021-12-01 → 2022-08-31Cons.Net sales
Revenue¥72.3bn2020-12-01 → 2021-11-30Cons.Net sales (5-year summary)
Revenue¥53.7bn2020-12-01 → 2021-08-31Cons.Net sales
Operating income¥426m2021-12-01 → 2022-08-31Cons.Operating income
Operating income¥2.0bn2020-12-01 → 2021-08-31Cons.Operating income
Ordinary income¥517m2021-12-01 → 2022-08-31Cons.Ordinary income
Ordinary income¥2.4bn2020-12-01 → 2021-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.0bn2020-12-01 → 2021-08-31Cons.Ordinary income
Profit before tax¥1.1bn2021-12-01 → 2022-08-31Cons.Income before income taxes
Profit before tax¥2.0bn2020-12-01 → 2021-08-31Cons.Income before income taxes
Net income (owners)¥606m2021-12-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.7bn2020-12-01 → 2021-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2020-12-01 → 2021-08-31Cons.Profit loss attributable to owners of parent
Net income¥601m2021-12-01 → 2022-08-31Cons.Profit loss
Net income¥1.1bn2020-12-01 → 2021-08-31Cons.Profit loss
Total assets¥62.9bnat 2022-08-31Cons.Assets
Total assets¥63.6bnat 2021-11-30Cons.Assets
Total assets¥62.0bnat 2021-08-31Cons.Total assets (5-year summary)
Total liabilities¥35.7bnat 2022-08-31Cons.Liabilities
Total liabilities¥36.5bnat 2021-11-30Cons.Liabilities
Net assets / equity¥27.1bnat 2022-08-31Cons.Net assets
Net assets / equity¥27.0bnat 2021-11-30Cons.Net assets
Net assets / equity¥26.5bnat 2021-08-31Cons.Net assets (5-year summary)
Cash and deposits¥7.2bnat 2022-08-31Cons.Cash and deposits
Cash and deposits¥10.9bnat 2021-11-30Cons.Cash and deposits
EPS (basic)¥15.172021-12-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.192022-06-01 → 2022-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.862020-12-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.22020-12-01 → 2021-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥3.942021-06-01 → 2021-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥46.632020-12-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥30.992020-12-01 → 2021-08-31Cons.Diluted earnings per share (5-year summary)
Equity ratio43.0%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio42.5%at 2021-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.8%at 2021-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 58
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-12-01 → 2022-08-31¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-12-01 → 2022-08-31¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-12-01 → 2022-08-31−¥29m
Reconciling Itemsreconcilingrevenue2021-12-01 → 2022-08-31−¥944m
Reconciling Itemsreconcilingrevenue intersegment2021-12-01 → 2022-08-31−¥944m
Reconciling Itemsreconcilingsegment profit2021-12-01 → 2022-08-31¥119m
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue2021-12-01 → 2022-08-31¥11.5bn
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue external2021-12-01 → 2022-08-31¥11.1bn
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2021-12-01 → 2022-08-31¥438m
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentsegment profit2021-12-01 → 2022-08-31¥169m
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2021-12-01 → 2022-08-31¥10.5bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2021-12-01 → 2022-08-31¥10.4bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2021-12-01 → 2022-08-31¥105m
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2021-12-01 → 2022-08-31−¥92m
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue2021-12-01 → 2022-08-31¥6.5bn
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue external2021-12-01 → 2022-08-31¥6.5bn
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2021-12-01 → 2022-08-31¥70m
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentsegment profit2021-12-01 → 2022-08-31−¥130m
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue2021-12-01 → 2022-08-31¥9.3bn
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue external2021-12-01 → 2022-08-31¥8.9bn
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue intersegment2021-12-01 → 2022-08-31¥331m
jpcrp040300-q3r_E02585-000Medicalreportable segmentsegment profit2021-12-01 → 2022-08-31¥389m
—segment totalrevenue2021-12-01 → 2022-08-31¥37.9bn
—segment totalrevenue external2021-12-01 → 2022-08-31¥36.9bn
—segment totalrevenue intersegment2021-12-01 → 2022-08-31¥944m
—segment totalsegment profit2021-12-01 → 2022-08-31¥336m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-08-31¥37.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-08-31¥36.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-12-01 → 2022-08-31¥944m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-08-31¥307m
Reconciling Itemsreconcilingrevenue2020-12-01 → 2021-08-31−¥975m
Reconciling Itemsreconcilingrevenue external2020-12-01 → 2021-08-31¥36,000
Reconciling Itemsreconcilingrevenue intersegment2020-12-01 → 2021-08-31−¥975m
Reconciling Itemsreconcilingsegment profit2020-12-01 → 2021-08-31−¥48m
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue2020-12-01 → 2021-08-31¥17.6bn
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue external2020-12-01 → 2021-08-31¥17.0bn
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2020-12-01 → 2021-08-31¥669m
jpcrp040300-q3r_E02585-000Fine Chemicalsreportable segmentsegment profit2020-12-01 → 2021-08-31¥1.0bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2020-12-01 → 2021-08-31¥20.9bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2020-12-01 → 2021-08-31¥20.8bn
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2020-12-01 → 2021-08-31¥29m
jpcrp040300-q3r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2020-12-01 → 2021-08-31−¥442m
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue2020-12-01 → 2021-08-31¥6.3bn
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue external2020-12-01 → 2021-08-31¥6.2bn
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2020-12-01 → 2021-08-31¥45m
jpcrp040300-q3r_E02585-000Industrial Chemicalsreportable segmentsegment profit2020-12-01 → 2021-08-31¥311m
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue2020-12-01 → 2021-08-31¥9.9bn
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue external2020-12-01 → 2021-08-31¥9.7bn
jpcrp040300-q3r_E02585-000Medicalreportable segmentrevenue intersegment2020-12-01 → 2021-08-31¥232m
jpcrp040300-q3r_E02585-000Medicalreportable segmentsegment profit2020-12-01 → 2021-08-31¥1.1bn
—segment totalrevenue2020-12-01 → 2021-08-31¥54.7bn
—segment totalrevenue external2020-12-01 → 2021-08-31¥53.7bn
—segment totalrevenue intersegment2020-12-01 → 2021-08-31¥975m
—segment totalsegment profit2020-12-01 → 2021-08-31¥2.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2020-12-01 → 2021-08-31¥54.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-12-01 → 2021-08-31¥53.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2020-12-01 → 2021-08-31¥975m
Total Of Reportable Segments And Otherssegment totalsegment profit2020-12-01 → 2021-08-31¥2.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 452
ItemContextValueUnit
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember9923513000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember6280640000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember54702737000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember54702737000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-975129000JPY
Net salesPrior1YTDDuration53727608000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember1013645000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember-442404000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember1119547000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember310664000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember2001453000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2001453000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-48050000JPY
Operating incomePrior1YTDDuration1953402000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember11090334000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember10444484000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember8932077000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember6459807000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember36926703000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1442000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember36928145000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration36928145000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember437908000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember105064000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember331105000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember70049000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember944127000JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember944127000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-944127000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember11528242000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember10549549000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember9263182000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember6529856000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember37870830000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1442000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember37872273000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-944127000JPY
Net salesCurrentYTDDuration36928145000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E02585-000FineChemicalsReportableSegmentsMember168829000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember-91860000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E02585-000MedicalReportableSegmentsMember388873000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E02585-000IndustrialChemicalsReportableSegmentsMember-130034000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember335809000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-28883000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember306925000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2021-11-30pass rounding
balance sheet identityconsolidated 2022-08-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-11-30pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2020-12-01/2021-08-31pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-08-31pass
statement vs summary · revenueconsolidated 2020-12-01/2021-08-31pass
statement vs summary · revenueconsolidated 2021-12-01/2022-08-31pass
statement vs summary · total assetsconsolidated 2021-11-30pass
statement vs summary · total assetsconsolidated 2022-08-31pass